✦ LIBER ✦

A phase I clinical trial of topical peptide p144 TGF-beta1 inhibitor in healthy volunteers

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

391 POSTER A Phase I randomized trial to

✍ R. Chetty; N. Dalton; M. Rimmer; N. Cockburn; I. Smith; A. Swaisland; J. Hargrea 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Safety and immunogenicity of a virus-lik

✍ Low, Jenny G.H.; Lee, Lawrence S.; Ooi, Eng Eong; Ethirajulu, Kantharaj; Yeo, Pa 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 755 KB

Safety and tolerability of lersivirine,

✍ John Davis; Frances Hackman; Marie-Noella Ndongo; HengWee Choo; Drew Lewis; Marg 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Phase I clinical trial safety of DNA- an

✍ Inese Cebere; Lucy Dorrell; Helen McShane; Alison Simmons; Sheena McCormack; Cla 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 289 KB

62 Pre-clinical evaluation of LYS6KAKT1,

✍ S. Geeganage; L. Sams; S. Joseph; T. Shepherd; R. Dally; L. Brail; T. Wang; A. C 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Safety and immunogenicity of a modified

✍ Felipe García; Juan Carlos López Bernaldo de Quirós; Carmen E. Gómez; Beatriz Pe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 533 KB